Neil Woodford has put 6% of his funds under management into GlaxoSmithKline (LSE: GSK), and when you look at the headline dividend yield it’s easy to see why. However, the company does face some challenges if it’s to be the sort of long-term cash generator this fund manager loves to buy and hold… Find out more in the investing video below!
Why Is Neil Woodford So Confident About GlaxoSmithKline plc?
VIDEO: One Fool puts GlaxoSmithKline plc (LON:GSK) under the spotlight.
The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.